Learn about the ISN’s work in advocacy below.
ISN-DOPPS Launch Survey to Assess Impact of COVID-19 on Kidney Units
The ISN and the Dialysis Outcomes and Practice Patterns Study (DOPPS) Program at Arbor Research Collaborative for Health in Michigan, United States, are conducting a survey on the impact of the COVID-19 pandemic on the care of patients undergoing chronic dialysis for the treatment of kidney failure. People with kidney diseases are particularly vulnerable to...
CORONATION: Upload Bulk Data to Register Patients Affected by COVID-19 on the Global COVID Registry
CORONATION, developed by the ISN in collaboration with the University of Cambridge, is the Coronavirus global observational registry, a data entry portal accessible to nephrologists worldwide to collect anonymous data on individual people with kidney disease and the COVID-19 infection. The initiative was set up in response to the growing need to gather data to...
World Kidney Day (WKD) 2021: Social Media Toolkit and Resource Library Available Now
The World Kidney Day (WKD) 2021 social media toolkit is now available on the WKD website. The toolkit contains information and resources to develop your social media campaign to raise awareness of kidney health and spread WKD’s message: Living well with kidney disease. The toolkit proposes ideas to help you create your own social media campaign, including visuals...
European Commission’s Pharmaceutical Strategy to Tackle Unmet Kidney Care Needs
The ISN welcomes the European Commission’s “Pharmaceutical Strategy for Europe,” released on November 25, 2020. Aspects of the strategy’s objectives are reflective of ISN’s vision of equitable access to kidney health and include: Re-thinking policies to stimulate innovation in areas of need, and patient-centered, health system-oriented pharmaceutical innovation to address long-term care settings. Investing in research and...